Form 4: Zoetis Executive Acquires Phantom Stock Units in Future-Dated Transaction
Insider Transaction Report
A Zoetis Inc. Executive Vice President acquired 161.0763 phantom stock units, with the transaction scheduled for July 11, 2025, as part of the company's Supplemental Savings Plan.
Summary
- Robert J. Polzer, Executive Vice President of Zoetis Inc. (ZTS), acquired 161.0763 phantom stock units.
- The transaction date for this acquisition is July 11, 2025.
- These phantom stock units were acquired under the Zoetis Supplemental Savings Plan.
- Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small amount of cash-equivalent investments, typically around 5% of the total value of the phantom stock unit.
- The value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
- The acquired units represent a total of 52.8675 common stock equivalents, valued at a reference price of $50.86 per common stock equivalent.
- Following this transaction, Mr. Polzer will beneficially own 10,785.4588 phantom stock units.
- The phantom stock units are settled in cash following the reporting person's separation from service.
- Transfers of these units into alternative investment funds are permissible at any time, provided Zoetis may limit the timing, frequency, and permissibility of such transfers.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. It's a routine insider acquisition of phantom stock units, which aligns executive interests with the company's long-term performance. The future transaction date indicates a pre-planned compensation event rather than a discretionary market purchase.
Positives
- The acquisition of phantom stock units by an Executive Vice President indicates continued alignment of management interests with shareholder value.
- Participation in the Zoetis Supplemental Savings Plan suggests a structured approach to executive compensation and retention.
Negatives
- No specific negatives are identified in this routine insider transaction filing.
Risks
- The value of the phantom stock units is tied to the market value of Zoetis common stock, meaning their value can fluctuate with stock performance.
- Zoetis may limit the timing, frequency, and permissibility of transfers from one investment fund to another within the Supplemental Savings Plan.
Future Outlook
The phantom stock units are settled in cash upon the reporting person's separation from service, indicating a long-term incentive structure. The future transaction date of July 11, 2025, suggests a pre-scheduled compensation event.
Industry Context
This is a routine insider transaction filing common across publicly traded companies, reflecting executive compensation and long-term incentive plans. It does not provide broader industry trends.
Comparison to Industry Standards
- This is a standard Form 4 filing for an executive's acquisition of phantom stock units, which are common forms of deferred compensation in large corporations.
- The general structure of this executive incentive plan aligns with typical practices in the pharmaceutical and animal health industry.
Stakeholder Impact
- Shareholders: The acquisition of phantom stock units by an executive aligns their interests with long-term shareholder value, as the value of these units is tied to the company's stock performance.
Next Steps
- The phantom stock units will be acquired on July 11, 2025.
- The phantom stock units will be settled in cash following the reporting person's separation from service.
Key Dates
| Date | Description |
|---|---|
| 07/11/2025 | Date of earliest transaction (acquisition of phantom stock units by Robert J. Polzer). |
| 07/15/2025 | Date the Form 4 was signed and filed. |
Keywords
Zoetis Inc., ZTS, SEC Form 4, Insider Transaction, Phantom Stock Units, Executive Compensation, Supplemental Savings Plan, Beneficial Ownership, Robert J. Polzer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.